Evidence map›Paper›PMID 30511293›Full record

ArticleClinical rheumatology2019

Correction to: the efficacy and safety of total glucosides of peony in the treatment of primary Sjögren's syndrome: a multi-center, randomized, double-blinded, placebo-controlled clinical trial.

Xia Liu, Xiaomei Li, Xiangpei Li, Zhijun Li, Dongbao Zhao, Shengyun Liu, Miaojia Zhang, Fengxiao Zhang, Ping Zhu, Jinwei Chen and 14 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Clinical rheumatology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Xia LiuDepartment of Rheumatology, China-Japan Friendship Hospital, No.2, East Yinghua Road, Chaoyang District, Beijing, 100029, China.
Xiaomei LiDepartment of Rheumatology and Immunology, Anhui Provincial Hospital, Hefei, Anhui, China.
Xiangpei LiDepartment of Rheumatology and Immunology, Anhui Provincial Hospital, Hefei, Anhui, China.
Zhijun LiDepartment of Rheumatology and Immunology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China.
Dongbao ZhaoDepartment of Rheumatology and Immunology, Changhai Hospital, Shanghai, China.
Shengyun LiuDepartment of Rheumatology and Immunology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Miaojia ZhangDepartment of Rheumatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Fengxiao ZhangDepartment of Rheumatology, Hebei General Hospital, Shijiazhuang, Hebei, China.
Ping ZhuDepartment of Clinical Immunology, Xi-Jing Hospital, Xi'an, Shaanxi, China.
Jinwei ChenDivision of Rheumatoid Immunology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Wei WeiDepartment of Rheumatology and Immunology, Tianjin Medical University General Hospital, Tianjin, China.
Bing LinDepartment of Rheumatology, China-Japan Friendship Hospital, No.2, East Yinghua Road, Chaoyang District, Beijing, 100029, China.
Yingbo ZhouDepartment of Rheumatology and Immunology, Anhui Provincial Hospital, Hefei, Anhui, China.
Jing ChenDepartment of Rheumatology and Immunology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China.
Yafei PangDepartment of Rheumatology and Immunology, Changhai Hospital, Shanghai, China.
Lei ZhangDepartment of Rheumatology and Immunology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Xiaoxuan SunDepartment of Rheumatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Zhibo YuDepartment of Rheumatology, Hebei General Hospital, Shijiazhuang, Hebei, China.
Yun JiaDepartment of Clinical Immunology, Xi-Jing Hospital, Xi'an, Shaanxi, China.
Jia WangDivision of Rheumatoid Immunology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Wenwen SunDepartment of Rheumatology and Immunology, Tianjin Medical University General Hospital, Tianjin, China.
Frank ChiuBoon Pharmaceutical Research Ltd., 45 Topanga, Irvine, CA, 92602, USA.
Liping PangBoon Pharmaceutical Research Ltd., 45 Topanga, Irvine, CA, 92602, USA.
Guochun WangDepartment of Rheumatology, China-Japan Friendship Hospital, No.2, East Yinghua Road, Chaoyang District, Beijing, 100029, China. guochunwang@hotmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The authors regret that the Fig. 1 in the original version of this article contained an error. In the left column, 211 cases in the TGP group should be followed up for 8 weeks before 12 weeks. The correct figure presented in this article.

Identifiers

PMID30511293

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.